Rahbar K - Search Results

1

Development of a multigenomic liquid biopsy (PROSTest) for prostate cancer in whole blood.

Modlin IM, Kidd M, Drozdov IA, Boegemann M, Bodei L, Kunikowska J, Malczewska A, Bernemann C, Koduru SV, Rahbar K. Modlin IM, et al. Among authors: rahbar k. Prostate. 2024 Apr 3. doi: 10.1002/pros.24704. Online ahead of print. Prostate. 2024. PMID: 38571290

2

Prostate Cancer Theranostics With ¹⁷⁷Lu-PSMA.

Ahmadzadehfar H, Seifert R, Afshar-Oromieh A, Kratochwil C, Rahbar K. Ahmadzadehfar H, et al. Among authors: rahbar k. Semin Nucl Med. 2024 Apr 2:S0001-2998(24)00024-2. doi: 10.1053/j.semnuclmed.2024.02.007. Online ahead of print. Semin Nucl Med. 2024. PMID: 38570288 Free article. Review.

3

Radiomics-Based Prediction Model for Outcome of Radioembolization in Metastatic Colorectal Cancer.

Roll W, Masthoff M, Köhler M, Rahbar K, Stegger L, Ventura D, Morgül H, Trebicka J, Schäfers M, Heindel W, Wildgruber M, Schindler P. Roll W, et al. Among authors: rahbar k. Cardiovasc Intervent Radiol. 2024 Apr;47(4):462-471. doi: 10.1007/s00270-024-03680-6. Epub 2024 Feb 28. Cardiovasc Intervent Radiol. 2024. PMID: 38416178

4

Quantification of [⁹⁹Tc]TcO₄^- in urine by means of anion-exchange chromatography-aerosol desolvation nebulization-inductively coupled plasma-mass spectrometry.

Horstmann M, Quarles CD Jr, Happel S, Sperling M, Faust A, Rahbar K, Clases D, Karst U. Horstmann M, et al. Among authors: rahbar k. Anal Bioanal Chem. 2024 May;416(11):2849-2858. doi: 10.1007/s00216-024-05149-4. Epub 2024 Jan 30. Anal Bioanal Chem. 2024. PMID: 38289357 Free PMC article.

5

Safety Analyses of the Phase 3 VISION Trial of [¹⁷⁷Lu]Lu-PSMA-617 in Patients with Metastatic Castration-resistant Prostate Cancer.

Chi KN, Armstrong AJ, Krause BJ, Herrmann K, Rahbar K, de Bono JS, Adra N, Garje R, Michalski JM, Kempel MM, Fizazi K, Morris MJ, Sartor O, Brackman M, DeSilvio M, Wilke C, Holder G, Tagawa ST. Chi KN, et al. Among authors: rahbar k. Eur Urol. 2024 Apr;85(4):382-391. doi: 10.1016/j.eururo.2023.12.004. Epub 2024 Jan 6. Eur Urol. 2024. PMID: 38185538 Free article. Clinical Trial.

6

The Imperative for Comparative Studies in Nuclear Medicine: Elevating ¹⁷⁷Lu-PSMA-617 in the Treatment Paradigm for mCRPC.

Rahbar K, Boegemann M. Rahbar K, et al. J Nucl Med. 2024 Feb 1;65(2):224-225. doi: 10.2967/jnumed.123.266952. J Nucl Med. 2024. PMID: 38176720 No abstract available.

7

Diagnostic Performance of [¹⁸F]TFB PET/CT Compared with Therapeutic Activity [¹³¹I]Iodine SPECT/CT and [¹⁸F]FDG PET/CT in Recurrent Differentiated Thyroid Carcinoma.

Ventura D, Dittmann M, Büther F, Schäfers M, Rahbar K, Hescheler D, Claesener M, Schindler P, Riemann B, Seifert R, Roll W. Ventura D, et al. Among authors: rahbar k. J Nucl Med. 2024 Feb 1;65(2):192-198. doi: 10.2967/jnumed.123.266513. J Nucl Med. 2024. PMID: 38164565 Free PMC article.

8

Multicenter development of a PET-based risk assessment tool for product-specific outcome prediction in large B-cell lymphoma patients undergoing CAR T-cell therapy.

Voltin CA, Paccagnella A, Winkelmann M, Heger JM, Casadei B, Beckmann L, Herrmann K, Dekorsy FJ, Kutsch N, Borchmann P, Fanti S, Kunz WG, Subklewe M, Kobe C, Zinzani PL, Stelljes M, Roth KS, Drzezga A, Noppeney R, Rahbar K, Reinhardt HC, von Tresckow B, Seifert R, Albring JC, Blumenberg V, Farolfi A, Flossdorf S, Gödel P, Hanoun C. Voltin CA, et al. Among authors: rahbar k. Eur J Nucl Med Mol Imaging. 2024 Apr;51(5):1361-1370. doi: 10.1007/s00259-023-06554-0. Epub 2023 Dec 20. Eur J Nucl Med Mol Imaging. 2024. PMID: 38114616 Free PMC article.

9

Renal and Multiorgan Safety of ¹⁷⁷Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy.

Herrmann K, Rahbar K, Eiber M, Sparks R, Baca N, Krause BJ, Lassmann M, Jentzen W, Tang J, Chicco D, Klein P, Blumenstein L, Basque JR, Kurth J. Herrmann K, et al. Among authors: rahbar k. J Nucl Med. 2024 Jan 2;65(1):71-78. doi: 10.2967/jnumed.123.265448. J Nucl Med. 2024. PMID: 38050121 Free PMC article.

10

177 Lu-DOTATATE (Lutathera) Therapy in 68 Ga-DOTATATE PET/CT-Negative Liver Metastases of a Neuroendocrine Tumor.

Ventura D, Roll W, Kasper HU, Rahbar K, Stegger L. Ventura D, et al. Among authors: rahbar k. Clin Nucl Med. 2023 Dec 1;48(12):e585-e587. doi: 10.1097/RLU.0000000000004888. Epub 2023 Oct 23. Clin Nucl Med. 2023. PMID: 37883194

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

153 results

Search Page